Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Characterization of nanoparticles for therapeutics.

Hall JB, Dobrovolskaia MA, Patri AK, McNeil SE.

Nanomedicine (Lond). 2007 Dec;2(6):789-803. Review.

PMID:
18095846
2.

Radical nanomedicine.

Rzigalinski BA, Meehan K, Davis RM, Xu Y, Miles WC, Cohen CA.

Nanomedicine (Lond). 2006 Dec;1(4):399-412. Review.

PMID:
17716143
3.

Integration column: biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications.

Rothenfluh DA, Hubbell JA.

Integr Biol (Camb). 2009 Jul;1(7):446-51. doi: 10.1039/b907627c. Epub 2009 May 28. Review.

PMID:
20023754
4.

Functionalized gold nanoparticles for drug delivery.

Han G, Ghosh P, Rotello VM.

Nanomedicine (Lond). 2007 Feb;2(1):113-23. Review.

PMID:
17716197
5.

Nanomedicine: evolutionary and revolutionary developments in the treatment of certain inflammatory diseases.

Szelenyi I.

Inflamm Res. 2012 Jan;61(1):1-9. doi: 10.1007/s00011-011-0393-7. Epub 2011 Nov 5. Review.

PMID:
22057873
6.

Theranostic nanoparticles engineered for clinic and pharmaceutics.

Ma X, Zhao Y, Liang XJ.

Acc Chem Res. 2011 Oct 18;44(10):1114-22. doi: 10.1021/ar2000056. Epub 2011 Jul 6. Review.

PMID:
21732606
7.
8.
9.

Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.

Gaumet M, Vargas A, Gurny R, Delie F.

Eur J Pharm Biopharm. 2008 May;69(1):1-9. Epub 2007 Aug 7. Review.

PMID:
17826969
10.

A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.

Hock SC, Ying YM, Wah CL.

PDA J Pharm Sci Technol. 2011 Mar-Apr;65(2):177-95. Review.

PMID:
21502077
11.

Therapeutic and diagnostic applications of nanoparticles.

Youns M, Hoheisel JD, Efferth T.

Curr Drug Targets. 2011 Mar 1;12(3):357-65. Review.

PMID:
20955146
12.

Nanomedicine: magnetic nanoparticles and their biomedical applications.

Banerjee R, Katsenovich Y, Lagos L, McIintosh M, Zhang X, Li CZ.

Curr Med Chem. 2010;17(27):3120-41. Review.

PMID:
20629620
13.

Nanomedicine: de novo design of nanodrugs.

Yang Z, Kang SG, Zhou R.

Nanoscale. 2014 Jan 21;6(2):663-77. doi: 10.1039/c3nr04535h. Review.

PMID:
24305636
14.
15.

Challenges in development of nanoparticle-based therapeutics.

Desai N.

AAPS J. 2012 Jun;14(2):282-95. doi: 10.1208/s12248-012-9339-4. Epub 2012 Mar 10. Review.

16.

Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.

Rahman M, Ahmad MZ, Kazmi I, Akhter S, Afzal M, Gupta G, Sinha VR.

Curr Drug Discov Technol. 2012 Dec;9(4):319-29. Review.

PMID:
22725687
17.

Targeted nanoparticle-based drug delivery and diagnosis.

Emerich DF, Thanos CG.

J Drug Target. 2007 Apr;15(3):163-83. Review.

PMID:
17454354
18.

Micro- and nanoparticles--medical applications.

J─âtariu A, Peptu C, Popa M, Indrei A.

Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):1160-9. Review.

PMID:
20191893
19.

Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.

Soares AF, Carvalho Rde A, Veiga F.

Nanomedicine (Lond). 2007 Apr;2(2):183-202. Review.

PMID:
17716120
20.

Uses of nanoparticles for central nervous system imaging and therapy.

Provenzale JM, Silva GA.

AJNR Am J Neuroradiol. 2009 Aug;30(7):1293-301. doi: 10.3174/ajnr.A1590. Epub 2009 Jul 17. Review.

Supplemental Content

Support Center